Despite donor organ shortage, a large proportion of possible donor lungs are declined for transplantation. Criteria for accepting/declining lungs remain controversial because of the lack of adequate tools to aid in decision-making. We collected, air-inflated, and froze a large series of declined/unused donor lungs and subjected these lung specimens to CT examination. Affected target regions were scanned by using micro-CT. Lungs from 28 donors were collected. Two lungs were unused, six were declined for non-allograft-related reasons (collectively denominated nonallograft declines, n = 8), and 20 were declined because of allograft-related reasons. CT scanning demonstrated normal lung parenchyma in only four of eight nonallograft declines, while relatively normal parenchyma was found in 12 of 20 allograft-related declines. CT and micro-CT examinations confirmed the reason for decline in most lungs and revealed unexpected (unknown from clinical files or physical inspection) CT abnormalities in other lungs. CT-based measurements showed a higher mass and density in the lungs with CT alterations compared with lungs without CT abnormalities. CT could aid in the decisionmaking to accept or decline donor lungs which could lead to an increase in the quantity and quality of lung allografts.
Despite donor organ shortage, a large proportion of possible donor lungs are declined for transplantation. Criteria for accepting/declining lungs remain controversial because of the lack of adequate tools to aid in decision-making. We collected, air-inflated, and froze a large series of declined/unused donor lungs and subjected these lung specimens to CT examination. Affected target regions were scanned by using micro-CT. Lungs from 28 donors were collected. Two lungs were unused, six were declined for non-allograft-related reasons (collectively denominated nonallograft declines, n = 8), and 20 were declined because of allograft-related reasons. CT scanning demonstrated normal lung parenchyma in only four of eight nonallograft declines, while relatively normal parenchyma was found in 12 of 20 allograft-related declines. CT and micro-CT examinations confirmed the reason for decline in most lungs and revealed unexpected (unknown from clinical files or physical inspection) CT abnormalities in other lungs. CT-based measurements showed a higher mass and density in the lungs with CT alterations compared with lungs without CT abnormalities. CT could aid in the decisionmaking to accept or decline donor lungs which could lead to an increase in the quantity and quality of lung allografts.
Introduction
The number of patients on the waiting list for organ transplantation is increasing yearly, while the number of donors is not increasing proportionally. Consequently, there is a donor organ shortage, resulting in a significant proportion of patients dying while on the waiting list. In approximately 70% of multiorgan donors, the lungs are declined for transplantation. This is related to the high susceptibility during the donation process to develop donor organ injury such as neurogenic pulmonary edema, aspiration, infection, and contusion (1).
In parallel, strict criteria have been described historically to select suitable donor lungs. Because the ideal lung donor (age <55 years, excellent blood gas parameters, short or no smoking history, and a clear chest radiograph) is extremely rare (2) , options are increasingly explored to expand the donor pool, including the use of extended-criteria donors (donors who do not match these ideal criteria) with acceptable short-and long-term results (3) . How far one can go in accepting extended lung donors without affecting the posttransplantation recipient outcomes is, however, unknown. Recently, ex vivo lung perfusion (EVLP) has been studied for its ability to assess and recondition lungs ex vivo before transplantation (4) . EVLP mainly allows a physiological evaluation of the graft. However, there is an ongoing debate regarding which criteria should be used to assess lung donor quality and which lungs should be selected for ex vivo assessment.
Only a few studies have described the exact reasons for declining donor lungs for transplantations. Ware and colleagues reported that a large proportion of declined donor lungs showed pulmonary arterial thrombosis and/ or pulmonary infarction, while bronchopneumonia, bronchiolitis, and emphysema were other common findings (5) . The same group showed that 41% of the declined lungs might have been acceptable for transplantation, which is a remarkably high number given the aforementioned donor organ shortage (6) . Interestingly, histological findings did not correlate with clinical characteristics such as oxygenation, radiography, or brain death-to-harvest interval. This clearly indicates that there is a large gap between the clinical parameters used to accept/decline donor lungs and the actual pathological changes within the donor lung. In 2006, Egan et al proposed the evaluation of donor lungs by using an ex vivo system that included CT scanning (7) . However, to date, no comprehensive research has been performed assessing a large series of lungs declined for transplantation on the basis of CT examination results. We hypothesize that the use of CT will provide deeper insight in the lung quality.
Material and Methods

Study design
We performed a retrospective analysis of donor lungs declined/not used for transplantation that were collected starting on July 2010 at a single center (UZ Gasthuisberg, Leuven, Belgium). This study is approved by our local hospital ethical committee (ML6385) and under existing Belgian law, which states that an organ that is considered unsuitable for transplantation can be released to approved research programs. In Leuven, there are approximately 60 lung transplantations per year with an average acceptance rate of 35-40%. The lungs collected for this study were declined by our local hospital surgical team or partly unused (lobar or single lung transplantation). The decision to decline lungs was not influenced by this study. The lungs were perfused and excised using our normal routine, inflated mildly, and procured after a cold anterograde flush in the donor with an additional retrograde flush at the back table. Excised lungs were transported semi-inflated on ice to our hospital, where the head surgeon definitively declined the lungs.
Lung assessment
The lungs were immediately transported to the laboratory, where one or both lungs (depending on availability, need for further pathological investigation, and use for primary cell isolation) were processed as described previously (8) . In brief, the lungs were cannulated in the main bronchus, inflated using 30 cm H 2 O pressure, and after deflation to 10 cm H 2 O, the lungs were fixed in the fumes of liquid nitrogen and stored in a À80°C freezer. Frozen whole lungs were scanned by using a Siemens Somatom scanner (Erlangen, Germany) at 120 kV, 110 mAs. The lung volume, weight, and density were calculated using OSIRIX software by manually delineating the lung and calculating total volume and the mean Hounsfield units in this volume. The latter was used to calculate lung mass and density. These ex vivo lung CT scans were reviewed by an experienced thoracic radiologist blinded to the reason for allograft decline. Afterward, the lungs were further processed by using a precooled bandsaw and systematically sampled to extract samples of 1.4 cm in diameter. Slice photographs were taken before and after sampling to ensure spatial matching of the core samples with the CT scans. Based on CT scans and macroscopic images, representative samples were subsequently scanned in frozen state using a micro-CT equipped with a freezing stage (Skyscan 1172; Bruker microCT, Kontich, Belgium). Micro-CT scans were reconstructed using company software (NRECON) and viewed by dataviewer. Histological examination was performed on selected micro-CT scans by fixing the lung cores in 4% formol and 96% acetone overnight at À20°C, followed by dehydration in increasing ethanol, embedding in paraffin and sectioning (slice thickness of 10 lm). Hematoxylin and eosin staining was performed according to the standard protocol, and the slices were inspected by an experienced lung pathologist (B.W.).
Statistics
Data are presented as mean AE SEM. Comparison between groups was performed using Mann-Whitney testing with GraphPad Prism 6.0. A value of p < 0.05 was considered statistically significant.
Results
Study population
We collected 35 lungs derived from 28 donors. Lung donors were predominantly male (21 [75%] of 28), with a mean age of 53 AE 4 years. Ten lungs were donated after cardiac death (DCD, 36%); smoking history was unknown in four (14%) of the 28 donors, while 18 (64%) of the 28 donors were nonsmokers and six (22%) of the 28 donors were smokers. Mean donor PO 2 was 406 AE 12 mm Hg, with only one donor having a PO 2 <300 mm Hg. Details of the individual lungs are shown in Table 1 .
Reasons for allograft decline/nonuse There were two nonused lungs; in one case, the lower and middle lung lobes were used for lobar transplantation; in the other case, the contralateral lung was used for a single lung transplantation. Six other lungs were declined because of reasons not related to the allograft (unexpected finding of kidney tumor at procurement, n = 2; unexpected finding of gastric tumor at procurement, n = 1; logistical issue, n = 1; laceration of the main artery, n = 1; recipient dying before implantation and no timely reallocation possible, n = 1). Twenty lungs were declined because of reasons related to the allograft (persistent emboli, n = 6; contusion, n = 2; emphysema, n = 2; infection, n = 2; secretions/inflammation and old [>75 years] donor, n = 2; enlarged vasculature, n = 1; sarcoidosis, n = 1; pleural infection, n = 1; pleural adhesion, n = 1; fibrosis; n = 1; edema, n = 1).
Non-allograft-related lung donor decline Because these lungs were declined for transplantation due to non-allograft-related reasons, we expected no CT abnormalities. Similarly, in the lungs that were not used because of lobar transplantation and single lung transplantation, we expected no CT alterations a priori. Therefore, we decided to group these lungs to reach a final number of eight. Surprisingly, we found only normal parenchyma in four of eight cases ( Figures 1A-C) and manifest CT alterations (pronounced ground-glass opacities with even consolidation in one case) in three other cases (37.5%), with one case showing only mild CT alterations (12.5%). The lung with laceration of the main artery during lung extraction showed evidence of severe pneumonia in the lower lobe ( Figures 1D-F) , while one of the lungs that was declined due to a kidney tumor unexpectedly showed alveolar infiltrates resembling infection, (D-F) Gross path slice, HRCT section, and micro-CT image of donor lung that could not be used due to rupture of the main artery, however, we observed severe parenchymal infiltrates consistent with infection. (G-I) Gross path slice, HRCT section, and micro-CT image of donor lung that was declined for transplantation because of the detection of a kidney nodule during prelevation; within the parenchyma, infiltrates consistent with infection were observed. (J-L) Gross path slice, HRCT section, and micro-CT image of donor lung where the contralateral lung was used for single lung transplantation that showed parenchymal alterations consistent with emphysema. which was not documented at the time of donor registration or in situ inspection ( Figures 1G-I) . The contralateral lung of the lung used for a single lung transplantation showed severe emphysema in the apical regions of the lung, despite the young age of the donor (35 years) (Figures 1J-L) . The last lung with mild CT alterations showed peripheral subpleural opacities.
Allograft-related lung donor decline Because these lungs were declined for reasons related to the donor organ, we expected CT alterations in all these lungs. Two lungs were declined because of an abnormal collapse test during procurement, together with an impression of emphysema at inspection. However, both lungs did not show emphysema on gross slice or CT examination (Figures 2A-B) , although some parenchymal alterations consistent with emphysema could be observed on micro-CT ( Figure 2C ). Six lungs were declined because of persistent emboli during retrograde flushing, however, none of these lungs showed severe parenchymal alterations on CT (normal, n = 4; mild tree-in-bud, n = 1, mild ground glass, n = 1), although blood vessels filled with blood could be seen in these lungs (Figures 2D-F ). Yet, this was also observed in lungs not declined because of emboli. In most lungs, we were able to confirm the reason for allograft decline using CT as, for example, interstitial fibrosis (reticular fibrosis, ground glass), pleural adhesion, and pulmonary edema were confirmed on CT exemplified in Figures 2G-I . Two lungs were rejected for a combination of old age and secretions/inflammation, which could not be confirmed on CT, while the lung declined for sarcoidosis (showing (A-C) Gross path slice, high-resolution CT (HRCT) section, and micro-CT image of donor lung that was declined because of emphysema, which was confirmed although only a limited degree of emphysema was observed, mostly apically. (D-F) Gross path slice, HRCT section, and micro-CT image of donor lung that was declined because of persistent large emboli despite adequate anterograde and retrograde flushing; the lung showed normal parenchyma. (G-I) Gross path slice, HRCT section, and micro-CT image of donor lung that was declined for suspicion of onset of interstitial fibrosis where CT and micro-CT confirmed mild parenchymal fibrosis.
enlarged lymph nodes during prelevation and cryosectioning, confirming sarcoidosis) did not seem to be affected according to our CT investigation.
The contusion and infection cases were especially of interest because CT scanning was able to demonstrate the extent of affected lung parenchyma. This is exemplified in Figure 3 , where A-C shows a donor lung declined for contusion, demonstrating severely damaged parenchyma (interstitial edema, ground glass, "crazy paving"), while Figures 3 D-F shows a case that was also rejected due to contusion but shows only mild ground glass in the lung periphery. Figures 4 A-C shows hematoxylin and eosin staining of an area that showed contusion on high-resolution CT and dense filling of the alveoli on micro-CT; alveolar hemorrhage and edema compatible with contusion were clearly observed. Similarly, in donor lungs declined because of infection, CT is able to discriminate the exact location and extent of infiltrates, which might be a valuable additional tool to aid in the final decision to accept or decline donor lungs. This is further exemplified in a donor lung pair declined because of infection where CT showed only mild infection, limited to the lower lobe of one lung (mild ground glass on CT), while most other lung parts where spared. On the other hand, another donor lung declined for infection showed extensive ground-glass opacities throughout the entire lung and therefore provides evidence that the lung may be unsuitable for transplantation. Figures 4 D-F shows a micro-CT image of a region where CT infiltrates could be observed. Histopathological analysis showed increased neutrophil presence in the alveoli consistent with acute pneumonia. Therefore, CT might be helpful to discriminate the extent and distribution of underlying injury and could be a useful parameter to assess lung quality.
General analysis
Of the total of 28 lungs analyzed for this study, 16 (61%) did not show severe CT alterations (emboli, n = 6; inflammation/secretion plus old age, n = 2; extrapulmonary tumors, n = 2; contusion, n = 1; recipient dying, n = 1; sarcoidosis, n = 1; logistics, n = 1; lobar transplant, n = 1; pleuritis contralateral lung, n = 1), while the other 12 showed extensive infiltrates, bleeding, emphysema, or fibrosis. 2 at prelevation (p = 0.62), but lungs with CT alterations were slightly younger (p = 0.024). There were no differences in other characteristics, like smoking history and gender.
Discussion
In this study, we investigated the use of CT as a tool to visualize abnormalities in a large series of nontransplanted donor lungs. We could demonstrate that CT scanning largely confirmed the reason for decline. Importantly, we also observed unexpected CT abnormalities, but on the other hand we also observed normal parenchyma in lungs declined for allograft-related reasons. We used micro-CT and matched histopathology of selected regions to validate CT findings that showed a good correlation.
To our knowledge, there are only a few groups reporting pathological findings in declined donor lungs. The only available reports describe a high proportion of declined donor lungs with pulmonary emboli [35% and 60%; (9)], which is higher than in our study (21%). It is, however, important to remark that in the older series, these organs were not flushed before investigation, which might explain the higher proportion of emboli. Moreover, these series are from the early transplantation era where experience in donor selection criteria was more limited. Interestingly, there was no correlation between chest radiography and the degree of pulmonary edema and histological abnormalities in these historic cases, stressing the need for additional (noninvasive) assessment of possible donor lungs.
We are not the first group to propose CT as an additional tool for donor lung assessment. Indeed, a group in North Carolina used CT scanning in six declined lungs to assess the impact of EVLP; however, scans were abnormal in all cases and confirmed chest radiography (showing infiltrates, which was the reason for decline). The main aim of their study was not to evaluate the usefulness of CT but to use CT to assess the effects of EVLP (7) . Similarly, in a recent study in pigs, CT was used to assess the effects of pharmacological treatment after brain death. CT analysis proved to be useful to evaluate lung morphology and revealed unexpected parenchymal changes in >50% of cases, which did not correlate with the blood gas measurements (10) .
Unexpectedly, our study demonstrated important CT alterations in lungs where a priori normal lung parenchyma was expected-for example, a large degree of emphysema in the contralateral lung of a transplanted lung or two other lungs showing unexpected CT infiltrates. If these grafts were not declined because of nonallograft reasons (e.g. renal tumor), these lungs would have been transplanted and could have caused increased morbidity or even death in the recipients. Although we acknowledge that there is no evidence that lungs with CT alterations could not be transplanted. This indicates that the tools and criteria currently used in clinical practice are not sufficiently sensitive to discriminate acceptable and nonacceptable lungs. Similarly, some lungs declined for allograft-related reasons showed a remarkable normal lung parenchyma on CT and might have been transplanted. Considering the extent of pathology on CT and the clinical donor history, we estimate that 11 of 20 allograft decline cases could have been suitable for transplantation after meticulous inspection (emboli, n = 6; contusion, n = 1; infection, n = 1; emphysema, n = 1; edema, n = 1; 55%). For example, in lungs with emboli, the emboli should be removed completely from the pulmonary artery before transplantation, which can be aided by thrombolysis with alteplase, which resulted in improved physiology (11) . Also, lungs with contusion can successfully be transplanted, especially when the donor is young and the extent of the damage is not too extensive. In our experience, time between trauma and donor procurement is of extreme importance, and a longer time frame (i.e. >48 hrs) allows a more accurate assessment of donor quality.
The recent introduction of EVLP is likely to affect the findings in declined donor lungs, because marginal lungs could be resuscitated to a transplantable condition. Similarly, the administration of broad-spectrum antibiotics to donor lungs declined for infection using the EVLP platform resulted in a decreased bacterial count in BAL in all donors lungs and improved pulmonary oxygenation and compliance and reduced pulmonary vascular resistance (12, 13) . Additional pharmacological treatment using EVLP is also possible and may allow further transplantation of lungs damaged by gastric acid inflammation (14) . Despite a growing EVLP experience, there is still a large debate regarding which parameters are most predictable regarding organ quality. We propose that a combination of the EVLP platform with a CT pre-and post-EVLP could provide extremely valuable information concerning the extent and location of disease and could assist in the final decision to whether to undertake transplantation. An example of the pre/post EVLP CT scans are shown in Figure 5 .
Another interesting finding is the increase in lung density in lungs with abnormal parenchyma compared with lungs with normal parenchyma. This could be used to relate the rather subjective CT findings to a quantifiable parameter that might aid in further decision-making. This could be further elaborated using a biomarker for lung acceptance such as endothelin 1 (15) and interleukin-1b/tumor necrosis factora (16) , which are already being proposed, among others, as promising markers.
In this study, we present the largest case series of declined donor lungs, but there are a number of limitations. First, in most cases, we were able to study only one of two explant lungs given other ongoing projects within the laboratory or need for in-depth pathological analysis, which might cause bias. Second, lungs were collected over a large time period during, which there was evolution in donor selection and management; therefore, it is possible that some lungs that were declined would have been transplanted.
We want to stress that CT is not the only tool that can be used for decision-making, but given its accessibility and simple practical use, it could serve as a valuable tool for lung selection. Indeed, donor history, blood gases of the pulmonary veins (17, 18) , and in situ inspection remain of utter importance in the decision. However, in lungs where there is reasonable doubt about the quality, an additional CT scan may help the decision. We acknowledge that sudden widespread use of CT might rather lead to a decrease in organ use because we suspect some degree of CT alterations in all lungs. Therefore, we are conducting a study in which ex vivo donor CT will be performed before transplantation and where surgeons are blinded for the results of the CT scanning. This will allow us to study the degree of CT alterations in "accepted" lungs and to associate CT findings with posttransplantation outcome (19) .
In conclusion, CT and micro-CT assessment of declined donor lungs showed abnormalities in lungs that were rejected for extra-allograft reasons but also normal Figure 5 : Illustration of the usefulness of pre/post ex vivo lung perfusion (EVLP) CT scans. The lungs were from a 36-year-old donor and were declined because of severe edema. On arrival, lungs were CT scanned (A) and were put on our experimental EVLP setup within the laboratory. After 4 hours of EVLP, the lungs were inflated and rescanned (C), and a large proportion of the infiltrates improved. At the same time, physiological parameters slightly increased during the 4 hours of EVLP (D and E).
parenchyma in lungs declined for allograft reasons. Therefore, we propose that CT could be a simple tool to assess lung quality and might help to increase donor lung quantity and quality.
